Super sugars

Antonio, Jose
May 1999
Joe Weider's Muscle & Fitness;May99, Vol. 60 Issue 5, p176
Focuses on the importance of glyconutrients in enhancing immunity. Definition of glyconutrients; Importance of programmed cell death; Study supporting the consumption of glyconutrients.


Related Articles

  • Vaccines: Enhancing glycan presentation increases vaccine efficacy. Flight, Monica Hoyos // Nature Reviews Drug Discovery;Jan2012, Vol. 11 Issue 1, p21 

    The article discusses the study regarding the improved glycoconjugate vaccine. It references the study "A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design," by F. Y. Avci and colleagues. It mentions that the development of the...

  • Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease. Baker, Carol J.; Carey, Vincent J.; Rench, Marcia A.; Edwards, Morven S.; Hillier, Sharon L.; Kasper, Dennis L.; Platt, Richard // Journal of Infectious Diseases;Mar2014, Vol. 209 Issue 5, p781 

    Background. Further reduction in the group B streptococcal (GBS) disease burden in neonates in the United States awaits an additional prevention strategy, such as maternal immunization.Methods. We performed a prospective, multicenter, case-control study of 33 mothers delivering neonates with...

  • Optimizing Protection Against Meningococcal Disease. Reisinger, Keith S.; Black, Steven; Stoddard, Jeffrey J. // Clinical Pediatrics;Jun2010, Vol. 49 Issue 6, p586 

    Neisseria meningitidis is a leading cause of bacterial meningitis and septicemia in the United States. Vaccines directed against meningococcal disease must elicit high and persistent titers of bactericidal antibodies against prevalent meningococcal serogroups and be highly efficacious in...

  • tirofiban.  // Davis's Drug Guide for Nurses, 9th edition;2005, p1036 

    Provides information on the antiplatelet agent and glycoprotein inhibitor tirofiban. Therapeutic indications; Mechanism of action; Pharmacokinetic characteristics; Contraindications and precautions; Adverse reactions and side effects.

  • High-energy Glycoconjugates: Synthetic Transformations of Carbohydrates Using Microwave and Ultrasonic Energy. Cioffi, Eugene A. // Current Topics in Medicinal Chemistry;Jan2008, Vol. 8 Issue 2, p152 

    Methods to transform carbohydrates are often complex and tedious, both due to the vast array of naturally occurring and synthetically designed scaffolds which may manifest meager to drastic reactivity, dependent upon the transformation sought and the stereogenic site chosen. In order to...

  • [General Articles] Recent Developments in the Synthesis and Discovery of Oligosaccharides and Glycoconjugates for the Treatment of Disease. Macmillan, Derek; Daines, Alison M. // Current Medicinal Chemistry;Dec2003, Vol. 10 Issue 24, p2733 

    The development of the first automated oligosaccharide synthesizer, along with new methods for screening carbohydrate ligand arrays is likely to lead to a rapid acceleration in both our ability to synthesize these molecules, and understand the roles of oligosaccharides and glycoconjugates in...

  • Highlights.  // Clinical Pharmacology & Therapeutics;Apr2012, Vol. 91 Issue 4, p568 

    The article offers news briefs related to pharmacology. It notes the health benefits and advantages of glycoconjugate vaccines which have been developed to protect against important bacterial pathogens. It describes the mechanics of tumor cell behavior which notes that mechanical compression...

  • Glycoconjugate Vaccine Containing Escherichia coli O157:H7 O-Antigen Linked with Maltose-Binding Protein Elicits Humoral and Cellular Responses. Ma, Zhongrui; Zhang, Huajie; Shang, Wenjing; Zhu, Faliang; Han, Weiqing; Zhao, Xueer; Han, Donglei; Wang, Peng George; Chen, Min // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Glycoconjugate is one of the most efficacious and safest vaccines against bacterial pathogens. Previous studies of glycoconjugates against pathogen E. coli O157:H7 focused more on the humoral responses they elicited. However, little was known about their cellular responses. In this study, we...

  • A Human Domain Antibody and Lewis Glycoconjugate That Inhibit Binding of Helicobacter pylori to Lewis Receptor and Adhesion to Human Gastric Epithelium. Younson, Justine; O'Mahony, Rachel; Haiqun Liu; Grant, Steven; Campion, Colin; Jennings, Lisa; Vaira, Dino; Kelly, Charles G.; Roitt, Ivan M.; Holton, John // Journal of Infectious Diseases;11/15/2009, Vol. 200 Issue 10, p1574 

    Increasing antibiotic resistance has prompted development of alternative approaches to antimicrobial therapy, including blocking microbial adhesion to host receptors. The BabA adhesin of Helicobacter pylori binds to fucosylated blood group antigens, such as the Lewisb antigens in human primate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics